ARCT icon

Arcturus Therapeutics
ARCT

Overview Fund Activity

147 hedge funds and large institutions have $453M invested in Arcturus Therapeutics in 2024 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 31 closing their positions.

Holders
147
Holders Change
-17
Holders Change %
-10.37%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
55
Reduced
47
Closed
31
Calls
$2.94M
Puts
$2.98M
Net Calls
-$39K
Net Calls Change
-$1.7M

Top Buyers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$9.31M
2
SSA
2
Schonfeld Strategic Advisors
New York
$14.4M
3
JGC
3
J. Goldman & Co
New York
$5.02M
4
Morgan Stanley
4
Morgan Stanley
New York
$9.14M
5
MB
5
MPM BioImpact
Massachusetts
$7.81M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$0
2
NAMA
2
Nikko Asset Management Americas
New York
$34.9M
3
RA
3
Royce & Associates
New York
$0
4
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$35M
5
PCM
5
Portolan Capital Management
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Northwestern Mutual Wealth Management
176
Northwestern Mutual Wealth Management
Wisconsin
– – -58 Closed
GWSG
177
GPS Wealth Strategies Group
Colorado
– – -10 Closed
CPA
178
Capital Performance Advisors
California
– – -2 Closed
CFGS
179
Concourse Financial Group Securities
Alabama
– – – –
Wolverine Trading
180
Wolverine Trading
Illinois
– – – –
Group One Trading
181
Group One Trading
Illinois
– – – –
C
182
Covestor
United Kingdom
$0 2 – –
4 5 6 7
8